Novel transcript, antisense to P2RX7

Novel transcript, antisense to P2RX7" refers to a long non-coding RNA (lncRNA) transcribed from the DNA strand opposite to the *P2RX7* gene. Such antisense RNAs do not encode proteins but may influence the expression of their sense counterparts (in this case, the purinergic receptor P2X7) through various mechanisms, including transcriptional interference, recruitment of chromatin modifiers, modulating DNA methylation, or RNA-RNA duplex formation that can affect mRNA stability or splicing[3][5]. The specific function and biological significance of ENSG00000286248 have not been clearly defined in the literature or databases analyzed. There are no direct drug interactions, disease biomarkers, or established disease links for this transcript. Its therapeutic targeting potential is unknown and likely limited, making it not a recognized "target" in the pharmacological sense. Antisense RNAs like this one sometimes regulate neighboring or overlapping protein-coding genes, for example modulating *P2RX7* expression epigenetically or post-transcriptionally[3][5]. The *P2RX7* gene encodes a well-characterized ligand-gated ion channel involved in immune signaling and is explored as a therapeutic target for inflammation and neurodegenerative disease[1][2][6], but the antisense transcript itself does not code for that receptor or have such a direct therapeutic relevance. ENSG00000286248 represents an antisense, likely long non-coding RNA, not a canonical therapeutic target, with limited functional or clinical annotation[3][5].

Other names

Antisense RNA to P2RX7P2RX7-ASlong non-coding RNA antisense to P2RX7